infections
Bacteria such as Enterococcus faecium and Limosilactobacillus reuteri are key in activating an immune receptor that boosts the activity of protective immune cells.
Azelaic acid travels from the gut to the lungs, where it activates immune cells to reduce inflammation and protect the lungs.
Prof. Flavia Indrio reflects on the main take-home messages from the congress, which brought together 32 leading international experts in microbiota research, allergy, nutrition, gut-brain axis and lung disease.
Paul Wilmes, University of Luxembourg, explores the concept of infective competence within a One Health framework.
VOS, an FDA-approved oral microbiota therapy, has been shown to reduce infection risk compared to traditional fecal transplants.
Segmented filamentous bacteria, or SFB, protect mice from these deadly infections by reprogramming specific immune cells in the lungs.
Dietary protein influences V. cholerae growth, metabolism, virulence, and competition with gut microbes.
Lantibiotic-producing gut bacteria can prolong gut imbalance and increase susceptibility to dangerous infections after antibiotics.
William Fusco, gastroenterologist at Policlinico Universitario Agostino Gemelli, highlighted a recently published pilot study on post-infectious irritable bowel syndrome (IBS) framed within microbial precision medicine and biomarker-driven care.
Immunology
Sponsored by
Three infant-derived strains isolated and developed by Coree srl that are potentially interesting for immune support.
